UBS Joint Venture to Acquire Credit Suisse Japan Wealth Management Business
By Helena Smolak
UBS's Japanese joint venture with Sumitomo Mitsui Trust Wealth Management is set to acquire Credit Suisse's wealth management business in Japan.
The Swiss lender said Monday that the partners will rebalance their investments in the joint venture so that the original UBS 51% and SuMi Trust Holdings 49% ownership structure is maintained, after it gained additional Credit Suisse client assets in Japan following UBS's merger with Credit Suisse.
The agreement "also underscores the belief both of our firms have in Japanese wealth management itself," said Zenji Nakamura, UBS SuMi's president, as well as UBS's Japan Country Head.
Write to Helena Smolak at helena.smolak@wsj.com
(END) Dow Jones Newswires
April 08, 2024 04:14 ET (08:14 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track